Generate Biomedicines, Inc. (NasdaqGS: GENB)
Salud · Biotecnología · US
10,38 $
+5,49 % hoy · -17,9 % 1 año
Generate Biomedicines, Inc. (NasdaqGS: GENB) opera en la industria de biotecnología dentro del sector salud. Su valor en bolsa es de 1,34 mil M $ y tiene 312 empleados.
En los últimos doce meses la acción ha bajado un 17,9 % y ha cotizado entre 9,84 y 22,67.
Tweenvest puntúa a Generate Biomedicines, Inc. en cuatro factores: calidad 44/100, valor 50/100. Su punto más fuerte es valor.
Evolución de la cotización de GENB
Cifras clave
- Capitalización
- 1,34 mil M $
- Ingresos (últ. 12 m)
- 21,07 M $
- PER
- -5,64
- BPA
- -2,83
- Rent. por dividendo
- —
- Beta (5 años)
- —
- Máximo 52 semanas
- 22,67 $
- Mínimo 52 semanas
- 9,84 $
- Volumen medio (3 m)
- —
- Acciones en circulación
- 129,10 M
- Empleados
- 312
- Próximos resultados
- —
Sobre Generate Biomedicines, Inc.
Generate Biomedicines, Inc. is a U.S.-based company pioneering generative biology, leveraging machine learning for the discovery and advancement of novel protein therapeutics. Their core approach involves developing drugs using protein-based modalities. The company's pipeline includes several key candidates: GB-0895, an investigational long-acting anti-TSLP monoclonal antibody designed for bi-annual dosing in severe asthma; GB-4362, an MMAE payload neutralizer monoclonal antibody; and GB-5267, a MUC16 CAR-T cell therapy. Integral to their work is the Generate Platform, a sophisticated system engineered to be versatile across diverse therapeutic areas and protein modalities. This platform combines computational innovation with scalable biohardware, allowing them to tackle therapeutic hurdles beyond the capabilities of traditional technologies. Established in 2018, the company was initially known as Generate Biologics, Inc. before rebranding to Generate Biomedicines, Inc. in February 2020. Its headquarters are located in Somerville, Massachusetts.
- ISIN
- US3709201004
- Fundada en
- 2018
- Cotiza desde
- 27 feb 2026
- Bolsa
- Nasdaq Global Select
- Divisa
- USD
Otras empresas de biotecnología
| Empresa | Capitalización | Precio | Día |
|---|---|---|---|
| Intellia Therapeutics, Inc.NasdaqGM: NTLA | 1,37 mil M $ | 9,77 $ | -0,11 % |
| Damora Therapeutics, Inc.NasdaqCM: DMRA | 1,36 mil M $ | 22,05 $ | -5,16 % |
| Shanghai OPM Biosciences Co., Ltd.SHSE: 688293 | 1,35 mil M $ | 63,07 CN¥ | -2,82 % |
| Nanobiotix S.A.ENXTPA: NANO | 1,34 mil M $ | 24,08 € | -2,51 % |
| MannKind CorporationNasdaqGM: MNKD | 1,33 mil M $ | 4,13 $ | -0,72 % |
| Mabwell (Shanghai) Bioscience Co., Ltd.SHSE: 688062 | 1,32 mil M $ | 20,30 CN¥ | -5,58 % |
| Ascentage Pharma Group InternationalSEHK: 6855 | 1,32 mil M $ | 28,10 HK$ | -3,70 % |
| Novavax, Inc.NasdaqGS: NVAX | 1,31 mil M $ | 7,87 $ | -1,13 % |